posted on 2022-02-07, 16:05authored byMaxime Pinard, Philippe Cloutier, Christian Poitras, Marie-Soleil Gauthier, Benoit Coulombe
The
PAQosome (particle for arrangement of quaternary structure)
is a 12-subunit HSP90 co-chaperone involved in the biogenesis of several
human protein complexes. Two mechanisms of client selection have previously
been identified, namely, the selective recruitment of specific adaptors
and the differential use of homologous core subunits. Here, we describe
a third client selection mechanism by showing that RPAP3, one of the
core PAQosome subunits, is phosphorylated at several Ser residues
in HEK293 cells. Affinity purification coupled with mass spectrometry
(AP-MS) using the expression of tagged RPAP3 with single phospho-null
mutations at Ser116, Ser119, or Ser121 reveals binding of the unphosphorylated
form to several proteins involved in ribosome biogenesis. In vitro phosphorylation assays indicate that the kinase
CK2 phosphorylates these RPAP3 residues. This finding is supported
by data showing that pharmacological inhibition of CK2 enhances the
binding of RPAP3 to ribosome preassembly factors in AP-MS experiments.
Moreover, the silencing of PAQosome subunits interferes with ribosomal
assembly factors’ interactome. Altogether, these results indicate
that RPAP3 phosphate group addition/removal at specific residues modulates
binding to subunits of preribosomal complexes and allows speculating
that PAQosome posttranslational modification is a mechanism of client
selection.